Stock Events

Stock Events

Diagnos 

$0.3384
11
-$0.00-0.47% 18:29 Today

Statistics

Day High
0.35
Day Low
0.3365
52W High
0.36
52W Low
0.13
Volume
40,069
Avg. Volume
102,004
Mkt Cap
16.79M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

1DecExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
Next
-0.01
-0.01
-0.01
-0.01
Expected EPS
N/A
Actual EPS
N/A

Financials

-7,002.38%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
47,175.89Revenue
-3.3MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow DGNOF. It's not an investment recommendation.
Toronto Dominion Bank
3
TD.TO
Microsoft
2
MSFT
NVIDIA
2
NVDA
Enbridge
2
ENB.TO

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Idexx Laboratories
IDXX
Mkt Cap43.72B
IDEXX Laboratories provides diagnostic and IT products for animal health, competing in the broader diagnostic market similar to Diagnos.
Abbott Laboratories
ABT
Mkt Cap194.62B
Abbott Laboratories offers a wide range of diagnostics products, including rapid diagnostics and laboratory diagnostics, directly competing with Diagnos' offerings.
Thermo Fisher Scientific
TMO
Mkt Cap230.05B
Thermo Fisher Scientific provides analytical instruments, reagents and consumables, and software services, competing in the diagnostics and research market.
Danaher
DHR
Mkt Cap151.89B
Danaher Corporation operates in the diagnostics sector, offering a broad portfolio of healthcare products that compete with Diagnos' diagnostic solutions.
Bio-Rad Laboratories
BIO
Mkt Cap10.37B
Bio-Rad Laboratories offers clinical diagnostics and life science research products, directly competing in the diagnostics market.
Labcorp
LH
Mkt Cap22.7B
Laboratory Corporation of America Holdings provides comprehensive clinical laboratory and end-to-end drug development services, competing in the diagnostics and healthcare service market.
Quest Diagnostics
DGX
Mkt Cap26.79B
Quest Diagnostics offers diagnostic testing, information, and services, directly competing with Diagnos in the diagnostics market.
Qiagen NV
QGEN
Mkt Cap8.9B
Qiagen provides sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research, competing in the diagnostics and research market.
Bruker
BRKR
Mkt Cap8.7B

About

DIAGNOS Inc. specializes in delivering technology-driven services, with its reach primarily extending across Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. A cornerstone of its offerings is Computer Assisted Retina Analysis (CARA), a web-based software application in the healthcare sector. This innovative tool is designed to aid medical professionals in identifying diabetic retinopathy, empowering eye care specialists to clearly visualize both normal anatomical features of the retina and any disease-related changes. Beyond its medical applications, the company also furnishes expert consulting services in the domains of data analytics and artificial intelligence. Established in 1998, DIAGNOS maintains its principal office in Brossard, Canada.
Show more...
CEO
Andre Larente
Employees
22
Country
Canada
ISIN
CA2524423068
WKN
000A2PH0N

Listings

F
DE
4D4A.F
STU
DE
4D4A.STU
OTC Link
US
DGNOF
V
CA
ADK.V

0 Comments

Share your thoughts

FAQ

What is Diagnos stock price today?▼
The current price of DGNOF is $0.34 USD — it has decreased by -0.47% in the past 24 hours. Watch Diagnos stock price performance more closely on the chart.
What is Diagnos stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Diagnos stocks are traded under the ticker DGNOF.
Is Diagnos stock price growing?▼
DGNOF stock has fallen by -5.98% compared to the previous week, the month change is a +61.37% rise, over the last year Diagnos has showed a +74.7% increase.
What is Diagnos market cap?▼
Today Diagnos has the market capitalization of 16.79M
When is the next Diagnos earnings date?▼
Diagnos is going to release the next earnings report on December 01, 2026.
What is Diagnos revenue for the last year?▼
Diagnos revenue for the last year amounts to 47,175.89 USD.
What is Diagnos net income for the last year?▼
DGNOF net income for the last year is -3.3M USD.
How many employees does Diagnos have?▼
As of September 04, 2026, the company has 22 employees.
In which sector is Diagnos located?▼
Diagnos operates in the Health & Wellness sector.
When did Diagnos complete a stock split?▼
The last stock split for Diagnos was on April 24, 2019 with a ratio of 1:10.
Where is Diagnos headquartered?▼
Diagnos is headquartered in Brossard, Canada.